Z
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A42.8 KBZS Pharma, Inc.Feb 16, 10:14 AM ET·0000902664-16-005729
- SC 13G/A38.7 KBZS Pharma, Inc.Feb 9, 4:36 PM ET·0001193125-16-455392
- 4/A8.9 KBZS Pharma, Inc.Dec 29, 5:06 PM ET·0000899243-15-010470
- 411.1 KBZS Pharma, Inc.Dec 21, 8:26 PM ET·0000899243-15-010249
- 424.3 KBZS Pharma, Inc.Dec 21, 8:23 PM ET·0000899243-15-010248
- 48.9 KBZS Pharma, Inc.Dec 21, 8:18 PM ET·0000899243-15-010245
- 48.9 KBZS Pharma, Inc.Dec 21, 8:14 PM ET·0000899243-15-010243
- 48.9 KBZS Pharma, Inc.Dec 21, 8:13 PM ET·0000899243-15-010242
- 47.2 KBZS Pharma, Inc.Dec 21, 8:10 PM ET·0000899243-15-010241
- 48.9 KBZS Pharma, Inc.Dec 21, 8:09 PM ET·0000899243-15-010240
Insiders
10- 3x5 Special Opportunity Fund, L.P.10% Owner
- AKKARAJU SRINIVASDirector
- Alexander RobertDirector, Chief Executive Officer
- Alta Partners VIII, L.P.10% Owner
- Asbury MarkSee Remarks
- Babler MartinDirector
- CHAMPSI FARAH10% Owner
- Devon Park Associates, LLC10% Owner
- Farrow Jeffrey SChief Financial Officer
- JANNEY DANIEL10% Owner
Tickers
No tickers on record
Addresses
business
508 WRANGLER DRIVE, SUITE 100
COPPELL, TX, 75019
mailing
508 WRANGLER DRIVE, SUITE 100
COPPELL, TX, 75019